ACT Genomics is focused in cutting-edge genomic profiling and empowering physicians and patients with evidence-based information. Its headquarters is based in Taiwan with offices located in Singapore, Hong Kong, Shanghai and Tokyo. ACT Genomics envisions to rewrite the existing model of cancer diagnostics, cancer treatment and cancer monitoring, through genetic testing and analysis for cancer prevention and manageability.